Test Code EZNT8 Zinc Transporter 8 (ZnT8) Antibody, Serum
Reporting Name
ZnT8 Ab, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Clinical distinction of type 1 from type 2 diabetes mellitus
Identification of individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes, and those with gestational diabetes)
Prediction of future need for insulin treatment in adult-onset diabetic patients
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Specimen Required
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 2 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Type
SerumSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
<15.0 U/mL
Interpretation
Seropositivity for ZnT8 autoantibody (≥15 IU/mL) is supportive of:
-A diagnosis of type 1 diabetes
-A high risk for future development of diabetes
-A current or future need for insulin therapy in patients with diabetes
Day(s) Performed
Tuesday, Thursday
Report Available
3 to 7 daysTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86341
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
EZNT8 | ZnT8 Ab, S | 76651-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
64926 | ZnT8 Ab, S | 76651-9 |